Continuous advances in genetic testing technologies and understanding of the genetic mechanisms of many diseases are fueling increased genetic testing utilization by providers across health care specialties. As of August 2017, approximately 75,000 genetic tests were available, and an estimated ten new tests were entering the market daily. Spending associated with germline genetic testing is heavily focused on reproductive genetic testing and hereditary cancer (Philips et al., 2018). This rapidly evolving genetic testing landscape proves to be difficult for many clinicians to navigate